Parakh Kapil, Kittleson Michelle M, Heidecker Bettina, Wittstein Ilan S, Judge Daniel P, Champion Hunter C, Barouch Lili A, Baughman Kenneth L, Russell Stuart D, Kasper Edward K, Sitammagari Kranthi K, Hare Joshua M
Department of Medicine, Johns Hopkins Bayview Medical Center, Baltimore, MD, USA.
Isr Med Assoc J. 2012 Nov;14(11):666-71.
Determining the prognosis of patients with heart failure is essential for patient management and clinical trial conduct. The relative value of traditional prognostic criteria remains unclear and the assessment of long-term prognosis for individual patients is problematic.
To determine the ability of clinical, hemodynamic and echocardiographic parameters to predict the long-term prognosis of patients with idiopathic dilated cardiomyopathy.
We investigated the ability of clinical, hemodynamic and echocardiographic parameters to predict the long-term prognosis of individual patients in a large, representative, contemporary cohort of idiopathic dilated cardiomyopathy (IDCM) patients referred to Johns Hopkins from 1997 to 2004 for evaluation of cardiomyopathy. In all patients a baseline history was taken, and physical examination, laboratory studies, echocardiogram, right heart catheterization and endomyocardial biopsy were performed.
In 171 IDCM patients followed for a median 3.5 years, there were 50 long-term event-free survivors (LTS) (median survival 6.4 years) and 34 patients died or underwent ventricular assist device placement or transplantation within 5 years (NLTS; non-long-term survivors) (median time to event 1.83 years. Established risk factors (gender, race, presence of diabetes, serum creatinine, sodium) and the use of accepted heart failure medications (angiotensin-converting enzyme inhibitors, angiotensin receptor blockers, beta blockers) were similar between the two groups. Although LTS had younger age, higher ejection fraction (EF) and lower New York Heart Association (NYHA) class at presentation, the positive predictive value of an EF < 25% was 64% (95% CI 41%-79%) and that of NYHA class > 2 was 53% (95% CI 36-69%). A logistic model incorporating these three variables incorrectly classified 29% of patients.
IDCM exhibits a highly variable natural history and standard clinical predictors have limited ability to classify IDCM patients into broad prognostic categories. These findings suggest that there are important host-environmental factors still unappreciated in the biology of IDCM.
确定心力衰竭患者的预后对于患者管理和临床试验开展至关重要。传统预后标准的相对价值仍不明确,且对个体患者长期预后的评估存在问题。
确定临床、血流动力学和超声心动图参数预测特发性扩张型心肌病患者长期预后的能力。
我们在一个具有代表性的当代大型特发性扩张型心肌病(IDCM)队列中,研究了临床、血流动力学和超声心动图参数预测个体患者长期预后的能力,该队列中的患者于1997年至2004年转诊至约翰霍普金斯医院以评估心肌病。对所有患者进行了基线病史采集,并进行了体格检查、实验室检查、超声心动图检查、右心导管检查和心内膜心肌活检。
在171例IDCM患者中,随访时间中位数为3.5年,有50例长期无事件存活者(LTS)(中位生存期6.4年),34例患者在5年内死亡、接受心室辅助装置置入或移植(非长期存活者;NLTS)(事件发生的中位时间1.83年)。两组之间既定的危险因素(性别、种族、糖尿病的存在、血清肌酐、钠)以及接受的心力衰竭药物(血管紧张素转换酶抑制剂、血管紧张素受体阻滞剂、β受体阻滞剂)的使用情况相似。尽管LTS在就诊时年龄较小、射血分数(EF)较高且纽约心脏协会(NYHA)分级较低,但EF<25%的阳性预测值为64%(95%CI 41%-79%),NYHA分级>2级的阳性预测值为53%(95%CI 36%-69%)。纳入这三个变量的逻辑模型错误分类了29%的患者。
IDCM表现出高度可变的自然病程,标准临床预测指标将IDCM患者分类到广泛预后类别的能力有限。这些发现表明,在IDCM生物学中仍存在未被认识的重要宿主-环境因素。